Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VEA vs GSK✓SelectedUSD · GSKVEA vs GSK performance historyLatest closeAs of-1.19%11/17
Stock and ETF performance explorer

VEA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+150.7%
GSK return
+148.6%
Excess return
+2.2%
Maximum drawdown
-60.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-2.3%+1.1%0.0%
7D-2.8%-3.0%+0.2%-1.2%
30D-3.0%+0.4%-3.3%-3.4%
3M-8.3%-1.2%-7.1%-8.3%
6M-1.7%+0.9%-2.6%-3.5%
YTD+8.9%+4.0%+4.9%+4.2%
1Y+14.3%+7.3%+7.0%+7.4%
3Y+62.0%+57.1%+4.9%+16.6%
5Y+50.2%+43.0%+7.2%+10.9%
10Y+151.9%+103.1%+48.9%+39.5%
All+150.7%+148.6%+2.2%+5.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling